Isoquercitrin attenuates osteoarthritis progression by targeting P53-mediated ferroptosis: A mechanistic study integrating network pharmacology and experimental validation
Top Cited Papers
- 7 February 2026
- journal article
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 153, 110306
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Hunan Province (2023JJ60061)
- Wuhan University (W202510486384)
- Wuhan University (W202510486374)
This publication has 38 references indexed in Scilit:
- What's new in osteoarthritis?Best Practice & Research Clinical Rheumatology, 2025
- Daidzin Inhibits Endoplasmic Reticulum Stress by Regulating FoxO1 Expression to Alleviate Osteoarthritis ProgressionPhytotherapy Research, 2025
- Isoquercitrin: From natural source to clinical candidate – Synthesis, pharmacology, and metabolic safetyFitoterapia, 2025
- AKR1C1 protects against intracerebral hemorrhage by suppressing neuronal cell death via the P53/SLC7A11/GPX4 axisBrain Research Bulletin, 2025
- Enhancing osteogenic bioactivities of coaxial electrospinning nano-scaffolds through incorporating iron oxide nanoparticles and icaritin for bone regenerationNano Research, 2024
- DNA demethylation of promoter region orchestrates SPI‐1‐induced ADAMTS‐5 expression in articular cartilage of osteoarthritis miceJournal of Cellular Physiology, 2023
- Cardamonin alleviates chondrocytes inflammation and cartilage degradation of osteoarthritis by inhibiting ferroptosis via p53 pathwayFood and Chemical Toxicology, 2023
- Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progressionEBioMedicine, 2022
- The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritisAgeing Research Reviews, 2021
- Diagnosis and Treatment of Hip and Knee OsteoarthritisJAMA, 2021